The respiratory tract microbiome: moving from correlation to causation
- PMID: 35512808
- DOI: 10.1183/13993003.03079-2021
The respiratory tract microbiome: moving from correlation to causation
Conflict of interest statement
Conflict of interest: R. Morton reports grants from Imperial College London (MRC Clinical Research Training Fellowship), outside the submitted work. Conflict of interest: A. Singanayagam reports grants from Medical Research Council (Clinician Scientist Fellowship), British Society of Antimicrobial Chemotherapy (COVID-19 grant) and British Medical Association (James Trust research grant); lecture honoraria from AstraZeneca; outside the submitted work.
Comment on
-
R othia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease.Eur Respir J. 2022 May 5;59(5):2101293. doi: 10.1183/13993003.01293-2021. Print 2022 May. Eur Respir J. 2022. PMID: 34588194 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical